Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to stop H.I.V. and for immune system discoveries.

The drug manufacturer has developed a pill that could bring about weight loss of as much as 13% in three months, according to results of a Phase 1 trial. The pill isn’t Ozempic—it’s called Amycretin—but like that drug it mimics the GLP-1 hormone, which suppresses people’s appetites. It also mimics amylin, which makes people feel full.

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

One of the researchers described the circumstances that led to the discovery as “serendipity.” This year’s prestigious Lasker medical awards recognize a trio of scientists without whom Ozempic and other blockbuster weight-loss drugs might not exist.

Weight-loss drugs like Ozempic are booming in popularity, but experts warn they aren't silver bullets for obesity.